-

Posts Tagged ‘cancer risk’

RSS

December 3rd, 2010

Podcast 110: ARBs (and anti-hypertensives, generally) pose no measurable cancer risk, meta-analysis shows.

This week’s guest, Dr. Sripal Bangalore, finds no evidence that use of the standard anti-hypertensive drugs increases risks for cancer. His meta-analysis did find, however, an indication that ARBs and ACE inhibitors, when used in combination, increase risks modestly. Even with the short follow-up, Bangalore says clinicians should find reassurance in the results. Listen [...]


November 2nd, 2010

Podcast 106: The barbershop and hypertension — a little off the top

OK, now what can be done to control hypertension among African American men? What about recruiting barbershops to put a shoulder to the wheel? They’re community centers, trusted sources of gossip and advice, and places of relaxation. In Texas, a group of researchers undertook a randomized trial in black-owned barbershops in which barbers took [...]


October 8th, 2010

Podcast 104: Reassurance on clopidogrel and omeprazole.

We welcome Dr. Danielle Bowen Scheurer to our conversational team this week She’s a hospitalist at the Medical University of South Carolina and an associate editor of Physician’s First Watch. Our guest is Dr. Deepak Bhatt, who has just published some reassuring results on omeprazole’s putative interaction with clopidogrel in the New England Journal [...]


June 18th, 2010

Podcast 92: Corticosteroids in COPD exacerbations — high-dose intravenous or low-dose oral?

A JAMA paper suggests that in all but the most severe exacerbations of COPD, it’s best to start off with low-dose oral corticosteroids rather than the higher-dose intravenous treatment that, contrary to guideline recommendations, almost everyone now gets. Our conversation this week is with the study’s first author, Dr. Peter Lindenauer. Visit the Journal [...]


April 9th, 2010

Podcast 82: Checklists save lives — lots of lives. Becoming a clinical automaton.

Repetitive tasks, like making sure to wash your hands after seeing each patient, may seem like drudgery, but they save patients’ lives. This week we talk with Prof. Elizabeth Robb and Sir Brian Jarman about their success at chopping hospital mortality rates with simple checklists. Sir Brian has offered to monitor your hospital’s stats [...]


July 2nd, 2009

Podcast 48: A conversation with Les Irwig, which your bone scanner won’t like to hear.

Scanning patients on bisphosphonates within the first 3 years of therapy is just wasted effort, and may even be misleading clinically. That’s what researchers conclude after reanalysis of FIT trial data on some 6500 women taking either alendronate or placebo. Prof. Les Irwig of the University of Sydney talks about his team’s findings and what [...]


Clinical Conversations

About the Podcast

To subscribe: Subscribe on iTunes

To have your comment included in a future podcast, call 617-440-4374. Please leave your name, number, and the podcast ID number.